Company intelligence / Profile preview
Bazelet Nehushtan
- Ownership
- Private
- Development stage
- Other
Overview
Bazelet Nehushtan is part of the largest medical cannabis group in Israel. It produces EU-GMP standard cannabinoid products including 84 terpene-enriched oils approved by the Israeli Ministry of Health. The company serves thousands of patients monthly with products tailored to specific populations such as women, seniors, dementia patients, children/adults with autism spectrum disorder, and others. Clinical results are not published but broad patient access indicates established efficacy/safety profile under national regulations
- Therapeutic areas
- PsychiatryNeurologyOther
- Modalities
- Small molecule (cannabinoids)Botanical extractOil formulationTopicalCapsule
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Bazelet Nehushtan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bazelet Nehushtan.